Akina

Private

ZurichHealthcare & Life Scienceshttps://www.akina.health/de/home

Last Round

Seed

Feb 3, 2025

Total Funding Raised

$6.37M

Company Overview

Akina is a health technology company that develops AI-powered medical software for remote therapeutic monitoring and digital physiotherapy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Telemedicine, Patient Engagement, Vertical SaaS

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

remote physiotherapymusculoskeletal rehabilitationdigital healthcomputer visionremote therapeutic monitoringRTMAI motion trackinghybrid caretelemedicinevirtual physical therapypatient engagementmedical softwarevertical SaaSdigital therapeuticsDTxAI rehab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akina Comps

Public and private peers based on sector, stage, and business model.

Akina comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Akina Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Feb 3, 2025
Grant	Oct 24, 2023
Pre Seed	Sep 1, 2022
Grant	Jul 7, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Florian Haufe

Chief Executive Officer

Executive Team

Michele Xiloyannis

Chief Technology Officer

Executive Team

Akina Investors

Notable investors and investment history

Akina investors
Investor	Rounds
Kickfund	Seed
Freigeist Capital	Seed
FAIR VC	Seed
Springboard Health Angels	Pre Seed
Venture Kick	Grant
Innosuisse	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 23, 2026
Grew 33% QoQ, from 18 to 24 employees.

View all signals

Akina Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Akina Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Akina's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich

Employee Range25

Year Founded2021

Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.